home > drugs a-z list > antara (fenofibrate) drug center > antara (fenofibrate) drug - overdosage and contraindications

There is no specific treatment for overdose with Antara (fenofibrate) . General supportive care of the patient is indicated, including monitoring of vital signs and observation of clinical status, should an overdose occur. If indicated, elimination of unabsorbed drug should be achieved by emesis or gastric lavage; usual precautions should be observed to maintain the airway. Because fenofibrate is highly bound to plasma proteins, hemodialysis should not be considered.

Antara (fenofibrate) is contraindicated in patients who exhibit hypersensitivity to fenofibrate.

Fenofibrate is contraindicated in patients with hepatic or severe renal dysfunction, including primary biliary cirrhosis, and patients with unexplained persistent liver function abnormality.

Fenofibrate is contraindicated in patients with preexisting gallbladder disease (see WARNINGS).

Last reviewed on RxList: 7/8/2008
This monograph has been modified to include the generic and brand name in many instances.